Lepu Medical Technology (300003.SZ) Receives Registration Approval for Rechargeable Implantable Deep Brain Neurostimulator System

Stock News11-04

Lepu Medical Technology (300003.SZ) announced that its subsidiary, Lepu Medical Electronic Instrument Co., Ltd., has obtained registration approval from the National Medical Products Administration (NMPA) for its self-developed rechargeable implantable deep brain neurostimulator, implantable deep brain neurostimulation electrode assembly, and implantable deep brain neurostimulation extension lead kit.

Deep brain stimulation (DBS) is a neurosurgical procedure that involves implanting electrodes in specific areas of the brain. These electrodes deliver constant or intermittent electrical currents from an implanted battery source, using low- or high-frequency pulses to modulate abnormal neural activity and alleviate symptoms.

The successful approval of the rechargeable implantable deep brain neurostimulator system marks a significant achievement for the company in the field of neuromodulation. This development supports Lepu Medical's strategic expansion into neuromodulation and provides a new treatment option for patients with Parkinson's disease.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1172774756?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 16:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172774756","market":"other","top_or_hot":-1,"title":"Lepu Medical Technology (300003.SZ) Receives Registration Approval for Rechargeable Implantable Deep Brain Neurostimulator System","media":"Stock News","content":"<p>Lepu Medical Technology (300003.SZ) announced that its subsidiary, Lepu Medical Electronic Instrument Co., Ltd., has obtained registration approval from the National Medical Products Administration (NMPA) for its self-developed rechargeable implantable deep brain neurostimulator, implantable deep brain neurostimulation electrode assembly, and implantable deep brain neurostimulation extension lead kit.</p>\n<p>Deep brain stimulation (DBS) is a neurosurgical procedure that involves implanting electrodes in specific areas of the brain. These electrodes deliver constant or intermittent electrical currents from an implanted battery source, using low- or high-frequency pulses to modulate abnormal neural activity and alleviate symptoms.</p>\n<p>The successful approval of the rechargeable implantable deep brain neurostimulator system marks a significant achievement for the company in the field of neuromodulation. This development supports Lepu Medical's strategic expansion into neuromodulation and provides a new treatment option for patients with Parkinson's disease.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lepu Medical Technology (300003.SZ) Receives Registration Approval for Rechargeable Implantable Deep Brain Neurostimulator System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLepu Medical Technology (300003.SZ) Receives Registration Approval for Rechargeable Implantable Deep Brain Neurostimulator System\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-04 16:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Lepu Medical Technology (300003.SZ) announced that its subsidiary, Lepu Medical Electronic Instrument Co., Ltd., has obtained registration approval from the National Medical Products Administration (NMPA) for its self-developed rechargeable implantable deep brain neurostimulator, implantable deep brain neurostimulation electrode assembly, and implantable deep brain neurostimulation extension lead kit.</p>\n<p>Deep brain stimulation (DBS) is a neurosurgical procedure that involves implanting electrodes in specific areas of the brain. These electrodes deliver constant or intermittent electrical currents from an implanted battery source, using low- or high-frequency pulses to modulate abnormal neural activity and alleviate symptoms.</p>\n<p>The successful approval of the rechargeable implantable deep brain neurostimulator system marks a significant achievement for the company in the field of neuromodulation. This development supports Lepu Medical's strategic expansion into neuromodulation and provides a new treatment option for patients with Parkinson's disease.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"","article_id":"1172774756","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172774756","pubTimestamp":1762243724,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Lepu Medical Technology (300003.SZ) announced that its subsidiary, Lepu Medical Electronic Instrument Co., Ltd., has obtained registration approval from the National Medical Products Administration...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300003":"乐普医疗","BK0188":"融资融券","BK0114":"健康中国","BK0196":"行业龙头","BK0042":"基因检测","BK0028":"国家队","BK0113":"养老产业","BK0251":"专用设备","BK0201":"可转债"},"translate_title":"乐普医疗科技（300003.SZ）可充电植入式深部脑神经刺激器系统获注册批件","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300003":1},"content_text":"Lepu Medical Technology (300003.SZ) announced that its subsidiary, Lepu Medical Electronic Instrument Co., Ltd., has obtained registration approval from the National Medical Products Administration (NMPA) for its self-developed rechargeable implantable deep brain neurostimulator, implantable deep brain neurostimulation electrode assembly, and implantable deep brain neurostimulation extension lead kit.\nDeep brain stimulation (DBS) is a neurosurgical procedure that involves implanting electrodes in specific areas of the brain. These electrodes deliver constant or intermittent electrical currents from an implanted battery source, using low- or high-frequency pulses to modulate abnormal neural activity and alleviate symptoms.\nThe successful approval of the rechargeable implantable deep brain neurostimulator system marks a significant achievement for the company in the field of neuromodulation. This development supports Lepu Medical's strategic expansion into neuromodulation and provides a new treatment option for patients with Parkinson's disease.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1172774756","isCrawlerRequest":true}